About Event

Within the PREDiCT series, Tumor Models San Francisco stands out as the primary platform for Immuno-Oncology research. This summit is dedicated to scientists trying to select the right IO candidates, improve the efficiency with which they advance through preclinical trials and more accurately translate from murine models into humans. To give the most comprehensive array of content we targeted these specific topic areas to ensure you don’t waste one minute at this year’s meeting:

  • Improving candidate and preclinical profiling through robust model selection and implementing cutting-edge technologies
  • Explore opportunities and limitations of PDX and Syngeneic models in IO, in addition consider 3D Organoid and other noveler models
  • Discuss a wide variety of therapy types and combinations to give the most comprehensive array of perspectives